Detalhe da pesquisa
1.
A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis.
Hepatology
; 67(5): 1890-1902, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29023915
2.
Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid.
Gastroenterology
; 148(4): 751-61.e8, 2015 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-25500425
3.
Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease.
Gastroenterology
; 145(3): 574-82.e1, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23727264